By G HossainPosted on May 13, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Azafaros will use the Series B haul to push lead asset nizubaglustat into late-stage studies for Niemann-Pick disease Type C and GM1/GM2 gangliosidoses later this year. Azafaros Raises $150M To Target Rare Neuro-Metabolic Diseases Post navigation State AI regulation ban tucked into Republican tax, fiscal bill10x Genomics Slashes 8% of Headcount in Savings Push